Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:23 AM
Ignite Modification Date:
2025-12-25 @ 4:23 AM
NCT ID:
NCT07032220
Eligibility Criteria:
Inclusion Criteria:
1. women aged 18-70 years
2. The primary breast lesion was confirmed as invasive breast cancer by core needle biopsy
3. Axillary lymph node metastasis confirmed by fine needle aspiration or core needle biopsy
4. plan to undergo neoadjuvant chemotherapy
5. operable breast cancer
6. Patients with good heart, lung, liver, and kidney function are suitable for surgery
7. Informed consent
Exclusion Criteria:
1. Surgery is not planned or impossible
2. Metastasis of supraclavicular lymph nodes
3. distant metastasis, excluding bone metastasis
4. previous ipsilateral axillary surgery or radiotherapy
5. Due to personal or family factors, the patient is unable to cooperate with the surgical treatment recommended by the doctor according to the condition (breast conserving surgery or radical surgery).
6. Patients with severe heart and lung diseases, uncontrolled infectious diseases and other non-tumor related diseases could not tolerate comprehensive treatment such as surgery and chemotherapy
7. Unable to sign the informed consent form due to mental illness or other reasons
8. Poor medical compliance, and the study group believed that the patients could not complete the trial treatment process and follow-up according to the standard
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT07032220
Study Brief:
Protocol Section:
NCT07032220